Picture of Ligand Pharmaceuticals Incorporated logo

LGND — Ligand Pharmaceuticals Incorporated News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Brief: Ligand Reports First Quarter 2023 Financial Results

May 4 (Reuters) - Ligand Pharmaceuticals Inc  LGND.O :
    * LIGAND REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS
    * 2023 FINANCIAL GUIDANCE RAISED
    * NET INCOME FROM CONTINUING OPERATIONS FOR Q1 OF 2023 WAS
$2.43
PER DILUTED SHARE
    * Q1 EARNINGS PER SHARE VIEW $0.89 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nBwq0Zkqa 
Further company coverage:  LGND.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Ligand Pharmaceuticals Incorporated

See all news